Hbk Investments L P Pfizer Inc Transaction History

Hbk Investments L P

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$45.75 - $56.69 $150,380 - $186,340	-3,287 Reduced 8.12%	37,173 $1.92 Million
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $550,754 - $816,401	13,329 Added 49.13%	40,460 $2.39 Million
Q2 2021 Aug 16, 2021	SELL	$35.91 - $40.68 $1.7 Million - $1.92 Million	-47,241 Reduced 63.52%	27,131 $1.06 Million
Q3 2019 Nov 14, 2019	SELL	$32.49 - $42.13 $23.3 Million - $30.2 Million	-716,058 Reduced 90.59%	74,372 $2.67 Million
Q1 2019 May 15, 2019	BUY	$37.5 - $41.2 $29.6 Million - $32.6 Million	790,430 New	790,430 $33.6 Million

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Hbk Investments L P, based on Form 13F filings with the SEC.

Stay updated on Hbk Investments L P with notifications on news.